Back to Search Start Over

Disposition of captopril in normal subjects.

Authors :
Kripalani KJ
McKinstry DN
Singhvi SM
Willard DA
Vukovich RA
Migdalof BH
Source :
Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 1980 May; Vol. 27 (5), pp. 636-41.
Publication Year :
1980

Abstract

The disposition of captopril, an angiotensin-converting enzyme inhibitor with antihypertensive properties, was studied in 10 normal male subjects after a single 100-mg tablet of 35S-labeled drug. Average absorption parameters for unchanged captopril in blood were Tmax 0.93 +/- 0.08 hr and Cmax 800 +/- 76 ng/ml. For total radioactivity in blood the values were Tmax 1.05 +/- 0.08 hr and Cmax 1,580 +/- 90 ng/ml (as captopril equivalents). Because of the curvilinearity of the semilogarithmic plots of blood concentrations of captopril:time, elimination half-life (t1/2) of unchanged drug could not be determined. At 1 hr unchanged captopril accounted for about 52% of total radioactivity in blood, and the dimeric disulfide metabolite of captopril accounted for about 10%. In the first 5 days after dosing, an average of about 68% of the radioactive dose was recovered in urine and 18% in feces. The distribution of radioactivity in the first 24-hr urine sample (66% of the dose) was 58% captopril (38% of dose), 2% captopril disulfide (1.5% of dose), and 40% unidentified polar metabolites (26% of dose).

Details

Language :
English
ISSN :
0009-9236
Volume :
27
Issue :
5
Database :
MEDLINE
Journal :
Clinical pharmacology and therapeutics
Publication Type :
Academic Journal
Accession number :
6989546
Full Text :
https://doi.org/10.1038/clpt.1980.90